Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Revelations And Resolutions, In Brief

Jan 23 2012

• By Lisa LaMotta and Jessica Merrill

Related Content

Despite Rival's Supply Problems, No Guarantee That Shire Will Re-File Replagal In U.S.

Apr 13 2011

HCV Buyup Continues As Bristol Offers $2.5 Billion For Inhibitex

Jan 09 2012

German HTA Assessment Knocks Back Gilenya In Europe

Jan 19 2012

Related Companies

Novo Nordisk A/S

Bristol Myers Squibb Company

Inhibitex, Inc.

Merck & Co., Inc.

Roche Holding AG

Johnson & Johnson

Novartis AG

Sanofi

Biogen, Inc.

Sanofi

Sanofi Genzyme

Takeda Pharmaceutical Co. Ltd.

Forest Laboratories, Inc.

Ironwood Pharmaceuticals, Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window